| RS1644755212 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS1644755604 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphataemia or rickets, Hypophosphataemia or rickets |
| RS1644756699 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS1644757200 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS1644757548 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1644777520 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1644799870 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644814606 |
UROD
|
Health Risk |
Pathogenic |
Familial porphyria cutanea tarda, Familial porphyria cutanea tarda |
| RS1644818073 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644819425 |
UROD
|
Health Risk |
Pathogenic |
— |
| RS1644826882 |
UROD
|
Health Risk |
Pathogenic |
— |
| RS1644831295 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1644833186 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1644835894 |
UROD
|
Health Risk |
Pathogenic |
— |
| RS1644838064 |
TMEM53
|
Health Risk |
Pathogenic |
TMEM53-related craniotubular dysplasia, Craniotubular dysplasia |
| RS1644839551 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644853541 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644859056 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644859651 |
STIL
|
Health Risk |
Likely pathogenic |
Microcephaly 7, primary |
| RS1644868869 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644886403 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1644888393 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644889088 |
TMEM53
|
Health Risk |
Pathogenic/Likely pathogenic |
TMEM53-related craniotubular dysplasia, Craniotubular dysplasia |
| RS1644891144 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644903899 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644908718 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644909838 |
AGRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1644913465 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644918844 |
CLCN6
|
Health Risk |
Conflicting classifications of pathogenicity |
12 conditions, Neurodegeneration |
| RS1644920219 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644929836 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1644931388 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644932281 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1644937659 |
C8B
|
Health Risk |
Likely pathogenic |
— |
| RS1644949519 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1644978399 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1644995145 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1644997083 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645023044 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1645025596 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645027632 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645038575 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1645047324 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645057147 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1645065317 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1645090090 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645092023 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645098684 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645128943 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645132367 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1645145092 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645149413 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645153275 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1645156886 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1645159594 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1645164432 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1645188053 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645192561 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1645249331 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS1645259682 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast carcinoma |
| RS1645260006 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645261795 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645264815 |
AGO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental disorder with language delay and behavioral abnormalities |
| RS1645267570 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645271555 |
AGO1
|
Health Risk |
Pathogenic |
AGO1-associated disorder, Intellectual disability |
| RS1645321968 |
VPS13D
|
Health Risk |
Pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS1645324873 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645327989 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645350030 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645358577 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1645359135 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Encephalopathy |
| RS1645359406 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645359691 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645363196 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645370714 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1645371113 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645377017 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645377413 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645377813 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645382242 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645392057 |
VPS13D
|
Health Risk |
Likely pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS1645411052 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1645413342 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645414208 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645416037 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645416288 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645419457 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645420669 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Encephalopathy, acute |
| RS1645421667 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645424505 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645426286 |
CPT2
|
Health Risk |
Likely pathogenic |
— |
| RS1645442171 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645443101 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1645443275 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1645445189 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1645561773 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645571595 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1645573077 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645575152 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1645575312 |
CDC42
|
Health Risk |
Likely pathogenic |
— |